Oral Oncology
Volume 46, Issue 8 , Pages 577-585, August 2010

Postoperative strategies after primary surgery for squamous cell carcinoma of the head and neck☆

  • Johannes A. Langendijk

      Affiliations

    • Department of Radiation Oncology, University Medical Center Groningen/University of Groningen, Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, University Medical Center Groningen, P.O. Box 30001, 9300 RB Groningen, The Netherlands. Tel.: +31 50 3611190; fax: +31 50 3611692.
    • ,
  • Alfio Ferlito

      Affiliations

    • Department of Surgical Sciences, ENT Clinic, University of Udine, Udine, Italy
    • ,
  • Robert P. Takes

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    • ,
  • Juan P. Rodrigo

      Affiliations

    • Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain
    • ,
  • Carl Suárez

      Affiliations

    • Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain
    • ,
  • Primo Strojan

      Affiliations

    • Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia
    • ,
  • Missak Haigentz Jr.

      Affiliations

    • Department of Medicine, Division of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
    • ,
  • Alessandra Rinaldo

      Affiliations

    • Department of Surgical Sciences, ENT Clinic, University of Udine, Udine, Italy

Received 24 February 2010; received in revised form 29 March 2010; accepted 29 March 2010. published online 20 April 2010.

Summary 

This review discusses the role of adjuvant treatment after curative surgery for patients with head and neck squamous cell carcinoma (HNSCC). In general, patients with unfavourable prognostic factors have a high-risk of loco-regional recurrence and subsequent worse survival after surgery alone and are therefore considered proper candidates for adjuvant treatment by either postoperative radiotherapy alone or postoperative chemoradiation. Selection of the most optimal adjuvant treatment strategy should be based on the most important prognostic factors.

In this review, the different treatment strategies will be discussed in general. More specifically, we will discuss the role of the interval between surgery and radiotherapy, the overall treatment time of radiation, the selection of target volumes for radiation and the value of adding concomitant chemotherapy to postoperative radiation.

Keywords: Head and neck cancer, Squamous cell carcinoma, Postoperative radiotherapy, Postoperative chemoradiation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ This paper was written by members and invitees of the International Head and Neck Scientific Group (www.IHNSG.com).

PII: S1368-8375(10)00135-1

doi:10.1016/j.oraloncology.2010.03.023

Oral Oncology
Volume 46, Issue 8 , Pages 577-585, August 2010

Article Tools